Page last updated: 2024-09-05

pyridine-2-azo-4-dimethylaniline cephalosporin and imipenem, anhydrous

pyridine-2-azo-4-dimethylaniline cephalosporin has been researched along with imipenem, anhydrous in 1 studies

Compound Research Comparison

Studies
(pyridine-2-azo-4-dimethylaniline cephalosporin)
Trials
(pyridine-2-azo-4-dimethylaniline cephalosporin)
Recent Studies (post-2010)
(pyridine-2-azo-4-dimethylaniline cephalosporin)
Studies
(imipenem, anhydrous)
Trials
(imipenem, anhydrous)
Recent Studies (post-2010) (imipenem, anhydrous)
16004,7843911,397

Protein Interaction Comparison

ProteinTaxonomypyridine-2-azo-4-dimethylaniline cephalosporin (IC50)imipenem, anhydrous (IC50)
Beta-lactamase Pseudomonas aeruginosa0.15

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bujdáková, H; Kallová, J; Kettner, M; Lausová, A1

Other Studies

1 other study(ies) available for pyridine-2-azo-4-dimethylaniline cephalosporin and imipenem, anhydrous

ArticleYear
In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Microbios, 1995, Volume: 84, Issue:339

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Chromogenic Compounds; Drug Resistance, Microbial; Gram-Negative Bacteria; Imipenem; Microbial Sensitivity Tests; Slovakia; Thienamycins

1995